Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of inhaled doxorubicin in treating patients
who have primary lung cancer or lung metastases.